PubRank

Y Ichihashi

Author PubWeight™ 30.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 1971 3.57
2 Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology 1971 2.06
3 N-terminal amino acid sequences of vaccinia virus structural proteins. Virology 1994 1.71
4 Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology 1990 1.58
5 Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J Virol 1984 1.38
6 Characterization of vaccinia polypeptides. Virology 1981 1.26
7 Adsorption and penetration of the trypsinized vaccinia virion. Virology 1980 1.22
8 Unit Complex of vaccinia polypeptides linked by disulfide bridges. Virology 1981 1.02
9 Changes in ocular astigmatism over the whole range of accommodation. Optom Vis Sci 1991 1.01
10 Proteolytic activation of vaccinia virus for the penetration phase of infection. Virology 1982 1.01
11 Vaccinia-specific hemagglutinin. Virology 1977 1.01
12 Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J Neuroimmunol 1995 0.99
13 Modification of vaccinia virus penetration proteins analyzed by monoclonal antibodies. Virology 1987 0.97
14 The activation of vaccinia virus infectivity by the transfer of phosphatidylserine from the plasma membrane. Virology 1983 0.96
15 The effect of proteolytic enzymes on the infectivity of vaccinia virus. Virology 1982 0.96
16 The function of the vaccinia hemagglutinin in the proteolytic activation of infectivity. Virology 1990 0.95
17 Studies on the nature of Marchal bodies (A-type inclusion) during ectromelia virus infection. Virology 1966 0.87
18 The relationship between poxvirus and A-type inclusion body during double infection. Virology 1968 0.83
19 Characterization of metal ion-implanted titanium oxide photocatalysts operating under visible light irradiation. J Synchrotron Radiat 1999 0.80
20 Target antigen of vaccinia-infected cells recognized by virus-specific cytotoxic T lymphocytes. Microbiol Immunol 1981 0.79
21 Toxic haloperidol reactions with observation of serum haloperidol concentration in two children. Dev Pharmacol Ther 1982 0.78
22 A morphological study in germfree mice (Salmonella infection). Exp Pathol (Jena) 1979 0.78
23 Biogenesis of poxviruses: relationship between a translation complex and formation of A-type inclusions. Virology 1973 0.78
24 Homovanillic acid, vanillylmandelic acid and 5-hydroxyindole-3-acetic acid are undetectable in urine of the muskrat. Chem Pharm Bull (Tokyo) 1985 0.77
25 Application of ion beam techniques for preparation of metal ion-implanted TiO2 thin film photocatalyst available under visible light irradiation: metal ion-implantation and ionized cluster beam method. J Synchrotron Radiat 2001 0.76
26 IgM anti-(GalNAc beta 1-4 Gal[3-2 alpha NeuAc] beta 1-) antibody-mediated cytotoxicity in a patient with amyotrophic lateral sclerosis-like disorder. Muscle Nerve 1992 0.76
27 A-type inclusion markers of wild white and other variola-related poxviruses. Jpn J Med Sci Biol 1976 0.75
28 [Basic and clinical evaluation of ceftezole (Celoslin) intravenous drip infusion in pediatric field (author's transl)]. Jpn J Antibiot 1980 0.75
29 [Fundamental and clinical evaluation of 9,3"-diacetylmidecamycin in pediatric field (author's transl)]. Jpn J Antibiot 1982 0.75
30 [Basic and clinical examinations of 6059-S in pediatrics (author's transl)]. Jpn J Antibiot 1981 0.75
31 [Comparison of kinetics and effectiveness against pseudomonas aeruginosa between intravenously and intramuscularly administered tobramycin; experimental study using diffusion chambers incubated in rabbit's peritoneal cavity (author's transl)]. Kansenshogaku Zasshi 1981 0.75
32 [Clinical investigation of cefadroxil in pediatric field (author's transl)]. Jpn J Antibiot 1981 0.75
33 [Basic and clinical examinations of CS-1170 in pediatrics (author's transl)]. Jpn J Antibiot 1979 0.75
34 [Experience with cefuroxime in pediatric field (author's transl)]. Jpn J Antibiot 1979 0.75
35 [Fundamental and clinical studies of cefotaxime in neonates and immature infants]. Jpn J Antibiot 1982 0.75
36 [Effect of i.v. immunoglobulins on experimental infections--especially in combination with antibiotics]. Kansenshogaku Zasshi 1982 0.75
37 [Pharmacokinetics study on gentamicin intravenous drip infusion in children]. Jpn J Antibiot 1983 0.75
38 A Creutzfeldt-Jakob disease agent (Echigo-1 strain) recovered from brain tissue showing the 'panencephalopathic type' disease. Neurology 1989 0.75
39 [A study of serum levels of cefazolin following a single intravenous dose in newborns, immature infants and younger children (author's transl)]. Jpn J Antibiot 1980 0.75
40 Determination of homovanillic acid in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1985 0.75
41 [Colonization of bacteria in man]. Nihon Ishikai Zasshi 1972 0.75
42 [Fundamental and clinical studies of tobramycin by intravenous drip infusion in pediatric field (author's transl)]. Kansenshogaku Zasshi 1981 0.75
43 Relationship between the stability of intestinal bacterial flora and several antibiotics; erythromycin, colimycin etc. Keio J Med 1966 0.75
44 Functional differences between the external and protoplasmic surfaces of plasma membranes in activating vaccinia virus infectivity. Virology 1982 0.75
45 [Basic and clinical studies on cefmenoxime in pediatric field]. Jpn J Antibiot 1982 0.75
46 [Fundamental and clinical studies of PC-904 in pediatrics (author's transl)]. Jpn J Antibiot 1978 0.75
47 Effects of antibiotics on platelet aggregation. Drugs 1988 0.75
48 [Fundamental and clinical studies of cefotiam in the field of pediatrics (author's transl)]. Jpn J Antibiot 1981 0.75
49 [The experimental and clinical studies on cefsulodin in the pediatric field]. Jpn J Antibiot 1982 0.75
50 [Study of cefroxadine in pediatrics regarding clinical efficacy and serum levels (author's transl)]. Jpn J Antibiot 1981 0.75
51 [Criteria for selection of the first, second and third generation cephem antibiotics. 3. Pediatrics]. Nihon Rinsho 1984 0.75
52 [Evaluation of blood concentrations and audiometric responses following administration of tobramycin in newborn infants--the brain stem auditory response]. Kansenshogaku Zasshi 1982 0.75
53 [Effects of pantethine on proliferation of intestinal bifidus bacteria in bottle-fed infants]. Nihon Shonika Gakkai Zasshi 1971 0.75
54 [Examination of blood levels and urinary excretion of cefmetazole in the mature and immature neonates (author's transl)]. Jpn J Antibiot 1981 0.75
55 [Infections caused by gram-negative bacillus]. Nihon Ishikai Zasshi 1967 0.75
56 [Evaluation of intravenous injection of cephalothin to new-born babies (author's transl)]. Jpn J Antibiot 1977 0.75